U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for acute heart failure, this patent would provide protection to ...

NEW CANAAN, CT / ACCESS Newswire / June 30, 2025 / Network-1 T, Inc. (NYSE:NTIP) announced today that it has initiated patent ...

Patent deals are getting done. Although the value of the patent deals currently being consummated has not increased in 2025 ...

1.3 million patients are hospitalized annually in the U.S. from acute heart failure and it is the #1 cause of hospitalization in patients >65 years old If istaroxime is approved in the US for ...

Patent supports the Company’s broader mission to advance minimally invasive, nerve-focused treatments across high-need ...

Moolec Science has obtained a US patent for its Piggy Sooy™ technology, a novel soybean engineered to produce high levels of ...

A federal jury in Delaware found that Apple's devices infringe on a patent related to 3G wireless communications.

Acute heart failure, or AHF, impacts millions of patients globally and istaroxime has previously completed two positive Phase 2 AHF studies and two positive early cardiogenic shock studies caused by ...

Senzime’s neuromuscular monitoring solution, TetraGraph system receives US patent: Uppsala, Sweden Thursday, July 3, 2025, 16:00 Hrs [IST] Uppsala-headquartered Senzime, a leadi ...

Bone Biologics seeks US patent for bone regeneration technology: Burlington, Massachusetts Monday, June 30, 2025, 16:00 Hrs [IST] Bone Biologics Corporation (Bone Biologics), a de ...